CITIC Lyon raised Fosun Pharma (02196.HK) H-share target pri
文 / 小金
2026-10-29 12:02:25
来源:亚金网
CITIC Lyon raised Fosun Pharma (02196.HK) H-share target price 1.9% to HK$27.1, and lifted its A-share PT, while maintaining an Outperform rating. The broker said Q3 results were broadly in line, with margin improvement driven by stronger sales of innovative products. Near-term catalyst: a global Phase III readout for AR1001 in Alzheimer’s. Continued commercialization progress for serplulimab in China and regulatory developments in the U.S. and Japan provide additional growth optionality.
